General Information
Version
5
Revision date
2011-07-05
Product name
CypHer 5E anti-VSV-G antibody, 250 µg
supplier name
GE Healthcare UK Ltd
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
msdslifesciences@ge.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]] Directive 1999/45/EC: Classification of the substance or mixture
Product definition
Mixture
Ingredient(s) with unknown acute toxicity
9.9%
Ingredients of unknown ecotoxicity
Percentage of the mixture consisting of ingredient(s) of unknown hazards to the aquatic environment: 14.8%
Signal word
Warning
Hazard statements
Causes serious eye irritation.
Prevention
Wear eye or face protection. Wash hands thoroughly after handling.
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
disodium hydrogenorthophosphate
Supplemental label elements
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings Not applicable.
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
Not available.
2.1 Classification of the substance or mixture
Product definition Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Eye Irrit. 2, H319 Ingredients of unknown toxicity Percentage of the mixture consisting of ingredient(s) of unknown toxicity: 9.9% Ingredients of unknown ecotoxicity Percentage of the mixture consisting of ingredient(s) of unknown hazards to the aquatic environment: 14.8% Classification according to Directive 1999/45/EC [DPD] The product is not classified as dangerous according to Directive 1999/45/EC and its amendments. Classification Not classified. See Section 16 for the full text of the R phrases or H statements declared above. See Section 11 for more detailed information on health effects and symptoms.